TH
Tyrosine 3-monooxygenase
As of the edition of 20 October 2026, TH (tyrosine 3-monooxygenase, UniProt P07101) has 2 drugs tested at it and 6 companies on the list, 0 on route A and 1 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P07101
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Inside the cell
- Solved structures
- 7
- Disease areas
- Cancer; Mental health; Hormones; Skin and connective tissue; Blood and lymph; Bones, joints and muscles; Digestive system; Heart and blood vessels
- Registered trials of its drugs
- 8
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Stopped | 1 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Racemetyrosine | Stopped | Phase 3 | none listed |
| Metyrosine | Marketed | Phase 2 | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 1 |
| Engaged | 2 |
| Undetermined | 3 |
| Total on the list | 6 |
| Company | Route |
|---|---|
| Ono Pharmaceutical | Route B |
The other 5 companies at TH
In the product6 companies in all; 5 are not named here, and no score is.
See the 6 companies at TH, ranked, with the facts behind eachRequest access. Nothing is shown until you do.